Nirmal Banda
Concepts (340)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Experimental | 30 | 2021 | 141 | 7.120 |
Why?
| | Complement Activation | 22 | 2025 | 407 | 4.030 |
Why?
| | Complement Pathway, Alternative | 13 | 2020 | 123 | 3.350 |
Why?
| | Arthritis, Rheumatoid | 15 | 2025 | 1184 | 3.190 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 8 | 2020 | 23 | 2.690 |
Why?
| | Complement System Proteins | 13 | 2025 | 308 | 2.650 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 7 | 2020 | 17 | 2.400 |
Why?
| | Complement Factor H | 6 | 2025 | 79 | 2.010 |
Why?
| | Synovial Membrane | 6 | 2025 | 119 | 1.740 |
Why?
| | Complement C3 | 15 | 2024 | 190 | 1.530 |
Why?
| | Complement Factor D | 6 | 2020 | 28 | 1.460 |
Why?
| | Mice, Knockout | 23 | 2021 | 3042 | 1.110 |
Why?
| | Collagen Type II | 8 | 2019 | 55 | 1.070 |
Why?
| | Receptors, Complement 3b | 3 | 2023 | 80 | 0.910 |
Why?
| | Antigen-Antibody Complex | 4 | 2017 | 72 | 0.870 |
Why?
| | Mice | 48 | 2025 | 17969 | 0.850 |
Why?
| | Complement C5 | 4 | 2015 | 34 | 0.840 |
Why?
| | Mice, Inbred C57BL | 23 | 2021 | 5866 | 0.830 |
Why?
| | Joints | 5 | 2020 | 105 | 0.820 |
Why?
| | Receptor, Anaphylatoxin C5a | 2 | 2015 | 29 | 0.810 |
Why?
| | Meniscus | 1 | 2023 | 23 | 0.780 |
Why?
| | Dextrans | 5 | 2024 | 85 | 0.750 |
Why?
| | Receptors, Complement 3d | 4 | 2023 | 140 | 0.710 |
Why?
| | Receptors, Complement | 3 | 2018 | 115 | 0.690 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2023 | 162 | 0.680 |
Why?
| | RNA, Small Interfering | 4 | 2020 | 627 | 0.670 |
Why?
| | Single-Chain Antibodies | 1 | 2020 | 17 | 0.670 |
Why?
| | Synoviocytes | 1 | 2020 | 18 | 0.660 |
Why?
| | Animals | 53 | 2025 | 37328 | 0.660 |
Why?
| | Immunoglobulin M | 2 | 2020 | 284 | 0.620 |
Why?
| | Osteoarthritis, Knee | 1 | 2023 | 270 | 0.620 |
Why?
| | RNA Interference | 2 | 2020 | 465 | 0.580 |
Why?
| | Complement Inactivator Proteins | 3 | 2009 | 40 | 0.570 |
Why?
| | Lectins | 2 | 2019 | 43 | 0.560 |
Why?
| | Collagen | 6 | 2017 | 452 | 0.560 |
Why?
| | Inflammation | 7 | 2025 | 2840 | 0.550 |
Why?
| | Recombinant Fusion Proteins | 4 | 2023 | 672 | 0.550 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2023 | 372 | 0.550 |
Why?
| | Antirheumatic Agents | 1 | 2020 | 306 | 0.540 |
Why?
| | Complement Pathway, Classical | 3 | 2014 | 20 | 0.530 |
Why?
| | Complement Inactivating Agents | 3 | 2025 | 66 | 0.480 |
Why?
| | Nanoparticles | 6 | 2025 | 481 | 0.470 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2015 | 50 | 0.450 |
Why?
| | Antibodies, Monoclonal | 5 | 2011 | 1456 | 0.440 |
Why?
| | Immunoglobulin G | 6 | 2011 | 882 | 0.420 |
Why?
| | Adenoviridae | 2 | 2014 | 199 | 0.420 |
Why?
| | RNA, Messenger | 9 | 2025 | 2815 | 0.410 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1486 | 0.400 |
Why?
| | Complement C3a | 2 | 2011 | 41 | 0.400 |
Why?
| | Complement C6 | 2 | 2011 | 7 | 0.390 |
Why?
| | Immunization, Passive | 2 | 2018 | 88 | 0.390 |
Why?
| | Contrast Media | 1 | 2014 | 476 | 0.350 |
Why?
| | Adipocytes | 1 | 2013 | 220 | 0.350 |
Why?
| | Autoantibodies | 7 | 2023 | 1466 | 0.340 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 463 | 0.320 |
Why?
| | Collectins | 2 | 2021 | 6 | 0.310 |
Why?
| | Complement C5a | 1 | 2009 | 53 | 0.310 |
Why?
| | Magnetite Nanoparticles | 4 | 2019 | 28 | 0.310 |
Why?
| | Mice, Inbred DBA | 5 | 2020 | 198 | 0.300 |
Why?
| | HIV-1 | 6 | 2002 | 882 | 0.300 |
Why?
| | Cytokines | 7 | 2021 | 2079 | 0.290 |
Why?
| | Complement Factor B | 3 | 2021 | 107 | 0.290 |
Why?
| | Humans | 43 | 2025 | 141284 | 0.290 |
Why?
| | Polysaccharides | 1 | 2008 | 87 | 0.280 |
Why?
| | Disease Models, Animal | 11 | 2021 | 4414 | 0.280 |
Why?
| | Fibroblasts | 1 | 2013 | 1018 | 0.270 |
Why?
| | Nanomedicine | 2 | 2025 | 46 | 0.260 |
Why?
| | Neutrophils | 4 | 2020 | 1113 | 0.260 |
Why?
| | Blotting, Western | 4 | 2013 | 1220 | 0.240 |
Why?
| | Male | 24 | 2025 | 70140 | 0.240 |
Why?
| | Gene Expression | 2 | 2022 | 1490 | 0.240 |
Why?
| | Leukocytes | 2 | 2019 | 293 | 0.240 |
Why?
| | Complement C1q | 4 | 2009 | 33 | 0.240 |
Why?
| | CD4 Antigens | 2 | 1999 | 141 | 0.230 |
Why?
| | Sialoglycoproteins | 2 | 2005 | 160 | 0.230 |
Why?
| | Complement C3-C5 Convertases | 2 | 2019 | 22 | 0.230 |
Why?
| | Cartilage, Articular | 2 | 2006 | 333 | 0.230 |
Why?
| | Immunohistochemistry | 4 | 2013 | 1724 | 0.220 |
Why?
| | Polyethylene Glycols | 3 | 2025 | 639 | 0.220 |
Why?
| | Cardiomegaly | 1 | 2025 | 172 | 0.210 |
Why?
| | Rheumatoid Factor | 1 | 2025 | 176 | 0.210 |
Why?
| | Glycoproteins | 2 | 2003 | 354 | 0.210 |
Why?
| | Hydrolases | 2 | 2017 | 54 | 0.210 |
Why?
| | Tissue Distribution | 2 | 2022 | 325 | 0.200 |
Why?
| | Keratinocytes | 1 | 2005 | 251 | 0.200 |
Why?
| | Disease Susceptibility | 2 | 2018 | 351 | 0.200 |
Why?
| | Antigens, CD34 | 3 | 2002 | 88 | 0.200 |
Why?
| | Cells, Cultured | 4 | 2020 | 4149 | 0.200 |
Why?
| | Protein Kinases | 1 | 2005 | 307 | 0.200 |
Why?
| | Mannose-Binding Lectin | 2 | 2016 | 20 | 0.200 |
Why?
| | Lipopolysaccharides | 3 | 2020 | 854 | 0.190 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2014 | 231 | 0.190 |
Why?
| | Interleukin-18 | 2 | 2003 | 236 | 0.190 |
Why?
| | Complement C3b Inactivator Proteins | 1 | 2021 | 9 | 0.180 |
Why?
| | Thrombin | 2 | 2021 | 166 | 0.180 |
Why?
| | HIV Infections | 6 | 2002 | 2981 | 0.180 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 621 | 0.180 |
Why?
| | Severity of Illness Index | 5 | 2022 | 2904 | 0.180 |
Why?
| | Macrophages | 6 | 2015 | 1478 | 0.180 |
Why?
| | Trypsin | 1 | 2021 | 73 | 0.170 |
Why?
| | Apoptosis | 4 | 2020 | 2487 | 0.170 |
Why?
| | Cartilage | 4 | 2019 | 191 | 0.170 |
Why?
| | Thymocytes | 1 | 2020 | 34 | 0.170 |
Why?
| | Cytotoxicity, Immunologic | 2 | 1998 | 221 | 0.160 |
Why?
| | Protein Binding | 5 | 2019 | 2233 | 0.160 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 108 | 0.160 |
Why?
| | Transfection | 2 | 2020 | 932 | 0.150 |
Why?
| | CD55 Antigens | 1 | 2019 | 29 | 0.150 |
Why?
| | Complement C3 Convertase, Alternative Pathway | 1 | 2018 | 2 | 0.150 |
Why?
| | Pancytopenia | 1 | 1999 | 9 | 0.150 |
Why?
| | Cattle | 3 | 2009 | 982 | 0.150 |
Why?
| | Lymphocyte Activation | 3 | 2003 | 1136 | 0.150 |
Why?
| | Antibodies | 2 | 2019 | 399 | 0.140 |
Why?
| | Macular Degeneration | 1 | 2020 | 186 | 0.140 |
Why?
| | Autoimmunity | 3 | 2016 | 908 | 0.140 |
Why?
| | Diphtheria Toxin | 1 | 1998 | 65 | 0.140 |
Why?
| | Complement C4 | 2 | 2009 | 26 | 0.140 |
Why?
| | Lymphocytes | 1 | 2020 | 390 | 0.140 |
Why?
| | Genetic Therapy | 3 | 2008 | 315 | 0.140 |
Why?
| | Archaeal Viruses | 1 | 2017 | 12 | 0.140 |
Why?
| | Atherosclerosis | 1 | 2021 | 402 | 0.130 |
Why?
| | Bone Marrow Cells | 1 | 1999 | 316 | 0.130 |
Why?
| | Monocytes | 1 | 2020 | 544 | 0.130 |
Why?
| | Ferric Compounds | 2 | 2014 | 55 | 0.130 |
Why?
| | Doxorubicin | 3 | 2025 | 369 | 0.130 |
Why?
| | Surface Properties | 2 | 2015 | 412 | 0.130 |
Why?
| | Genetic Variation | 2 | 2021 | 993 | 0.130 |
Why?
| | Interleukin-1 | 4 | 2005 | 970 | 0.130 |
Why?
| | Bleomycin | 1 | 2018 | 239 | 0.130 |
Why?
| | Female | 13 | 2025 | 75814 | 0.120 |
Why?
| | Coated Materials, Biocompatible | 1 | 2016 | 65 | 0.120 |
Why?
| | T-Lymphocyte Subsets | 2 | 2003 | 413 | 0.120 |
Why?
| | Fetal Blood | 1 | 1998 | 335 | 0.120 |
Why?
| | Opsonin Proteins | 1 | 2015 | 20 | 0.120 |
Why?
| | Proteolysis | 1 | 2016 | 173 | 0.120 |
Why?
| | Mucin-5B | 1 | 2018 | 221 | 0.120 |
Why?
| | Benzimidazoles | 1 | 2017 | 191 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 1 | 2018 | 462 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2018 | 507 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 983 | 0.110 |
Why?
| | Biomarkers | 2 | 2018 | 4180 | 0.110 |
Why?
| | Spleen | 4 | 2008 | 512 | 0.110 |
Why?
| | Synovial Fluid | 2 | 2011 | 72 | 0.110 |
Why?
| | Signal Transduction | 3 | 2020 | 5116 | 0.110 |
Why?
| | T-Lymphocytes | 4 | 2021 | 1996 | 0.110 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2600 | 0.110 |
Why?
| | Mice, Inbred NZB | 1 | 2014 | 16 | 0.110 |
Why?
| | Polymerase Chain Reaction | 3 | 2020 | 1050 | 0.110 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2014 | 37 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 849 | 0.110 |
Why?
| | Ross River virus | 1 | 2014 | 23 | 0.110 |
Why?
| | Adult | 7 | 2025 | 39319 | 0.110 |
Why?
| | Peptide Fragments | 1 | 1998 | 696 | 0.110 |
Why?
| | Alphavirus Infections | 1 | 2014 | 45 | 0.100 |
Why?
| | Transduction, Genetic | 1 | 2014 | 135 | 0.100 |
Why?
| | Middle Aged | 7 | 2025 | 34658 | 0.100 |
Why?
| | Immunity, Innate | 2 | 2017 | 847 | 0.100 |
Why?
| | Species Specificity | 1 | 2014 | 573 | 0.100 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 31 | 0.100 |
Why?
| | Lymphocyte Subsets | 2 | 2003 | 87 | 0.100 |
Why?
| | Genotype | 1 | 2018 | 1854 | 0.100 |
Why?
| | Biological Transport | 3 | 2020 | 409 | 0.100 |
Why?
| | Interleukin-8 | 2 | 2005 | 268 | 0.100 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 630 | 0.100 |
Why?
| | Mice, Inbred NOD | 1 | 2014 | 599 | 0.090 |
Why?
| | HIV Envelope Protein gp120 | 1 | 1992 | 61 | 0.090 |
Why?
| | Alternative Splicing | 1 | 2014 | 232 | 0.090 |
Why?
| | Dogs | 2 | 2025 | 423 | 0.090 |
Why?
| | Carotid Artery Thrombosis | 1 | 2011 | 7 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1261 | 0.090 |
Why?
| | Complement Membrane Attack Complex | 1 | 2011 | 38 | 0.090 |
Why?
| | Liver | 1 | 2020 | 1821 | 0.090 |
Why?
| | Amidines | 1 | 2011 | 14 | 0.090 |
Why?
| | HIV | 1 | 1992 | 248 | 0.090 |
Why?
| | Knee Joint | 1 | 2015 | 411 | 0.090 |
Why?
| | Ornithine | 1 | 2011 | 28 | 0.090 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2018 | 666 | 0.080 |
Why?
| | Rats | 3 | 2025 | 5556 | 0.080 |
Why?
| | RNA, Catalytic | 2 | 2002 | 189 | 0.080 |
Why?
| | Aged | 3 | 2025 | 24836 | 0.080 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 716 | 0.080 |
Why?
| | Acquired Immunodeficiency Syndrome | 3 | 1999 | 232 | 0.080 |
Why?
| | Lymph Nodes | 3 | 2008 | 494 | 0.080 |
Why?
| | Blood Coagulation | 1 | 2011 | 268 | 0.080 |
Why?
| | Binding Sites | 2 | 2021 | 1311 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2004 | 1220 | 0.080 |
Why?
| | Interleukin-6 | 2 | 2005 | 775 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2091 | 0.080 |
Why?
| | Serum | 1 | 2009 | 58 | 0.080 |
Why?
| | Receptors, CCR5 | 2 | 2000 | 61 | 0.080 |
Why?
| | Osteoarthritis | 1 | 2011 | 202 | 0.070 |
Why?
| | Foot | 1 | 2009 | 99 | 0.070 |
Why?
| | Drug Combinations | 1 | 2009 | 365 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 1994 | 1111 | 0.070 |
Why?
| | Zymosan | 1 | 2007 | 40 | 0.070 |
Why?
| | Immune Sera | 1 | 2007 | 76 | 0.070 |
Why?
| | Cations, Divalent | 1 | 2007 | 47 | 0.070 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 835 | 0.070 |
Why?
| | Peptides | 1 | 2013 | 971 | 0.070 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2005 | 255 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2012 | 857 | 0.060 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 855 | 0.060 |
Why?
| | Calcium | 2 | 2012 | 1175 | 0.060 |
Why?
| | DNA | 1 | 2012 | 1440 | 0.060 |
Why?
| | Gene Transfer Techniques | 3 | 2008 | 177 | 0.060 |
Why?
| | Interferon-gamma | 3 | 2004 | 784 | 0.060 |
Why?
| | COP9 Signalosome Complex | 1 | 2005 | 5 | 0.060 |
Why?
| | Phosphorylation | 2 | 2012 | 1753 | 0.060 |
Why?
| | Renin-Angiotensin System | 1 | 2025 | 77 | 0.060 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 56 | 0.060 |
Why?
| | Lung | 1 | 2018 | 4051 | 0.060 |
Why?
| | Extracellular Fluid | 1 | 2004 | 35 | 0.050 |
Why?
| | Mice, SCID | 3 | 2002 | 367 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2003 | 387 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2024 | 162 | 0.050 |
Why?
| | Citrulline | 2 | 2017 | 44 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 272 | 0.050 |
Why?
| | Injections, Intradermal | 1 | 2003 | 11 | 0.050 |
Why?
| | Cross-Linking Reagents | 2 | 2015 | 208 | 0.050 |
Why?
| | HeLa Cells | 1 | 2005 | 642 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1059 | 0.050 |
Why?
| | Hindlimb | 1 | 2003 | 133 | 0.050 |
Why?
| | Lymphocyte Count | 1 | 2003 | 167 | 0.050 |
Why?
| | Receptors, CXCR4 | 2 | 2002 | 88 | 0.050 |
Why?
| | Superoxide Dismutase | 1 | 2004 | 346 | 0.050 |
Why?
| | Cell Count | 1 | 2003 | 319 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1362 | 0.040 |
Why?
| | Blood Sedimentation | 1 | 2021 | 43 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2021 | 118 | 0.040 |
Why?
| | Rats, Long-Evans | 1 | 2021 | 122 | 0.040 |
Why?
| | Homozygote | 1 | 2021 | 199 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2003 | 2165 | 0.040 |
Why?
| | Sequence Deletion | 1 | 2021 | 183 | 0.040 |
Why?
| | Antigen-Presenting Cells | 1 | 2021 | 158 | 0.040 |
Why?
| | Necrosis | 1 | 2021 | 245 | 0.040 |
Why?
| | Bone and Bones | 2 | 2017 | 312 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2002 | 305 | 0.040 |
Why?
| | Organ Specificity | 2 | 2016 | 310 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 2 | 2002 | 408 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1761 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2021 | 389 | 0.040 |
Why?
| | Retinal Pigment Epithelium | 1 | 2020 | 77 | 0.040 |
Why?
| | Choroidal Neovascularization | 1 | 2020 | 57 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2021 | 170 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2005 | 718 | 0.040 |
Why?
| | Ferrosoferric Oxide | 1 | 2019 | 24 | 0.040 |
Why?
| | HIV Seronegativity | 1 | 1999 | 30 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2021 | 416 | 0.040 |
Why?
| | Cardiology | 1 | 2021 | 286 | 0.040 |
Why?
| | Fetal Tissue Transplantation | 1 | 1998 | 36 | 0.040 |
Why?
| | Tomography, Optical Coherence | 1 | 2020 | 258 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2020 | 321 | 0.040 |
Why?
| | Clone Cells | 1 | 1999 | 267 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 1999 | 119 | 0.030 |
Why?
| | A549 Cells | 1 | 2018 | 74 | 0.030 |
Why?
| | Extremophiles | 1 | 2017 | 2 | 0.030 |
Why?
| | HLA-DR Antigens | 1 | 1999 | 222 | 0.030 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2019 | 125 | 0.030 |
Why?
| | Sulfolobus | 1 | 2017 | 11 | 0.030 |
Why?
| | Proteomics | 2 | 2017 | 1137 | 0.030 |
Why?
| | Rabbits | 1 | 2018 | 664 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 96 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3793 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 156 | 0.030 |
Why?
| | Epitopes | 1 | 2019 | 476 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2021 | 2146 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 686 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 361 | 0.030 |
Why?
| | Phylogeny | 1 | 2021 | 997 | 0.030 |
Why?
| | Oxygen | 1 | 2021 | 986 | 0.030 |
Why?
| | Sheep | 1 | 2018 | 868 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 939 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2018 | 542 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2019 | 426 | 0.030 |
Why?
| | Sodium Hydroxide | 1 | 2014 | 8 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 448 | 0.030 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2015 | 77 | 0.030 |
Why?
| | Half-Life | 1 | 2014 | 145 | 0.030 |
Why?
| | Endocytosis | 1 | 2015 | 169 | 0.030 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 1995 | 92 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 329 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1244 | 0.020 |
Why?
| | Particle Size | 1 | 2014 | 403 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 420 | 0.020 |
Why?
| | Gamma Rays | 1 | 1992 | 56 | 0.020 |
Why?
| | Surface Plasmon Resonance | 1 | 2012 | 88 | 0.020 |
Why?
| | Mannose-Binding Lectins | 1 | 2011 | 10 | 0.020 |
Why?
| | CD59 Antigens | 1 | 2011 | 20 | 0.020 |
Why?
| | Clonal Anergy | 1 | 2012 | 52 | 0.020 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2011 | 25 | 0.020 |
Why?
| | Blood Platelets | 1 | 2015 | 387 | 0.020 |
Why?
| | Epidermolysis Bullosa Acquisita | 1 | 2011 | 6 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1576 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1483 | 0.020 |
Why?
| | Temperature | 1 | 2014 | 668 | 0.020 |
Why?
| | Pemphigoid, Bullous | 1 | 2011 | 8 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3577 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2808 | 0.020 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2012 | 132 | 0.020 |
Why?
| | Protein-Arginine Deiminases | 1 | 2011 | 16 | 0.020 |
Why?
| | Chlorides | 1 | 2011 | 137 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 173 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 2390 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 858 | 0.020 |
Why?
| | Immunoglobulin A | 1 | 2011 | 214 | 0.020 |
Why?
| | DNA Damage | 1 | 1992 | 430 | 0.020 |
Why?
| | Base Sequence | 2 | 2003 | 2170 | 0.020 |
Why?
| | Chondrocytes | 1 | 2011 | 229 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 2011 | 273 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2008 | 404 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2008 | 336 | 0.020 |
Why?
| | Adiponectin | 1 | 2008 | 243 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2012 | 3345 | 0.010 |
Why?
| | Chemokine CXCL2 | 1 | 2003 | 42 | 0.010 |
Why?
| | Phenotype | 1 | 2012 | 3172 | 0.010 |
Why?
| | Antibody Formation | 1 | 2004 | 295 | 0.010 |
Why?
| | rev Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 6 | 0.010 |
Why?
| | Gene Products, rev | 1 | 2002 | 6 | 0.010 |
Why?
| | Gene Products, tat | 1 | 2002 | 22 | 0.010 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 25 | 0.010 |
Why?
| | Mitogens | 1 | 2002 | 56 | 0.010 |
Why?
| | Chemokines | 1 | 2003 | 223 | 0.010 |
Why?
| | DNA Primers | 1 | 2003 | 507 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2002 | 99 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2003 | 397 | 0.010 |
Why?
| | Thymus Gland | 1 | 2002 | 316 | 0.010 |
Why?
| | Cell Lineage | 1 | 2002 | 352 | 0.010 |
Why?
| | CCR5 Receptor Antagonists | 1 | 2000 | 6 | 0.010 |
Why?
| | Colony-Forming Units Assay | 1 | 2000 | 94 | 0.010 |
Why?
| | Immunophenotyping | 1 | 2000 | 325 | 0.010 |
Why?
| | Down-Regulation | 1 | 2000 | 636 | 0.010 |
Why?
| | Cell Line | 1 | 2002 | 2863 | 0.010 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2002 | 670 | 0.010 |
Why?
| | Liver Transplantation | 1 | 2002 | 768 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2002 | 1983 | 0.010 |
Why?
| | Macaca | 1 | 1995 | 65 | 0.010 |
Why?
| | Simian Immunodeficiency Virus | 1 | 1995 | 92 | 0.010 |
Why?
| | RNA, Viral | 1 | 1995 | 695 | 0.010 |
Why?
| | Child, Preschool | 1 | 1995 | 11511 | 0.000 |
Why?
| | Child | 1 | 1995 | 22390 | 0.000 |
Why?
|
|
Banda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|